Cell IDx
Cell IDx is a San Diego-based immunodiagnostics company founded in 2013 that develops multiplexed cellular immunodiagnostics technology for immune-cell profiling, serving research and clinical diagnostics markets with a small 1-10 person team.
- Company typePrivate
- Founded2013
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cell IDx does
Cell IDx is a privately held, for-profit immunodiagnostics company founded in 2013 and headquartered in San Diego, California. The company describes itself as the "technology leader in multiplexed cellular immunodiagnostics," indicating it develops technology for simultaneously analyzing multiple cellular immune markers within a single diagnostic workflow, serving research, translational, and clinical diagnostics markets that require detailed immune-cell profiling.
The company is operated by a very small team of 1-10 employees under the leadership of Founder, CEO, and CSO David Schwartz, with scientific direction anchored by co-founder and scientific advisor Stephen J. Kron. Specific product names, platform architectures, regulatory clearances, pricing models, customer segments, and distribution channels are not disclosed in the supplied data; the available evidence supports only a high-level characterization of the business as a niche multiplexed immunodiagnostics technology provider.
Capitalization to date is modest: the company has at least one disclosed funding round totaling approximately $1.34M raised on 2020-09-29 (investors and lead investor unspecified in the source data). The combination of micro headcount, single-digit-million total disclosed funding, and absence of disclosed revenue or customer information indicates Cell IDx is operating at an early commercial or pre-commercial stage with limited public financial visibility.
Cell IDx firmographics
Firmographics- Name
- Cell IDx
- Website
- https://cellidx.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cell IDx is a San Diego-based immunodiagnostics company founded in 2013 that develops multiplexed cellular immunodiagnostics technology for immune-cell profiling, serving research and clinical diagnostics markets with a small 1-10 person team.
- Ownership category
- akta.pro rank
Cell IDx industry classification
Industry- Product category
- Clinical Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where Cell IDx is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Cell IDx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
Cell IDx product offering
Product offeringCore offering
Cell IDx develops and sells multiplexed cellular immunodiagnostic products and related technology for detecting cellular immune markers. The company focuses on enabling simultaneous measurement of multiple immune-cell-related targets to support diagnostic and research workflows. Founded in 2013 and based in San Diego, it serves as a specialized provider in the immunodiagnostics market.
Differentiator
Problem solved
Functional benefit
Companies that use Cell IDx
Customer profileIdeal customer profiles1 record
Cell IDx technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Cell IDx partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Cell IDx competitors and assessment
Company assessmentDirect peers
- Akoya Biosciences: Offers multiplexed spatial immunophenotyping platforms (CODEX/Phenoptics) used for cellular immunodiagnostics in research and translational settings. Comparable to Cell IDx as a focused multiplexed cellular/immunology assay provider serving translational and pharma customers.
- 10x Genomics: Provides single-cell and spatial multi-omics platforms (Chromium, Visium, Xenium) widely adopted in immunology research. Comparable to Cell IDx as a multiplexed cellular profiling platform provider, though serving a broader single-cell market than Cell IDx's targeted immunodiagnostics focus.
- Standard BioTools (formerly Fluidigm): Develops and commercializes mass cytometry and other high-multiplex cellular analysis platforms used in immunology and immuno-oncology research. Directly comparable to Cell IDx as a provider of multiplexed cellular profiling tools and assays for biomarker and translational research.
- Cytek Biosciences: Manufactures advanced full-spectrum flow cytometry instruments and reagents used for deep immunophenotyping. Comparable to Cell IDx as a provider of high-dimensional cellular immunodiagnostics tools, particularly through flow cytometry-based multiplexed panels.
- NanoString Technologies: Provides multiplexed gene expression and spatial biology platforms (nCounter, GeoMx, CosMx) used in immunology and immuno-oncology research. Directly comparable to Cell IDx in delivering high-plex cellular/molecular readouts for translational and pharma biomarker work.
Broad incumbents
- Becton, Dickinson and Company (BD): A global medical technology company with a major life sciences presence in flow cytometry (BD FACSDiscover, BD CellView Image) and clinical immunology. Comparable to Cell IDx through its broad cellular immunodiagnostics instruments, reagents, and clinical flow cytometry offerings.
- Beckman Coulter Life Sciences: A large incumbent in flow cytometry, immunology reagents, and clinical diagnostics (Cytobank, DxFLEX, Navios lines). Comparable to Cell IDx as an established immunodiagnostics provider, though operating across a much broader portfolio rather than focusing solely on multiplexed cellular assays.
- Thermo Fisher Scientific: Operates one of the broadest portfolios of immunology, flow cytometry, and clinical diagnostics tools through brands such as Invitrogen, Gibco, and the former Affymetrix/Olink platforms. Comparable to Cell IDx as a large incumbent supplier of immunodiagnostics reagents and instrumentation across research and clinical markets.
Emerging players
- BioLegend (part of Revvity/PerkinElmer): A leading supplier of antibodies and reagents for immunology, flow cytometry, and multiplexed immunoassays (e.g., LEGENDplex). Comparable to Cell IDx in serving researchers developing multiplexed cellular immunodiagnostics, though primarily a reagent vendor rather than an assay/services provider.
- Cell Signaling Technology: Provides highly validated antibody and immunoassay products used in cellular immunology and signaling research, including multiplexed antibody panels. Comparable to Cell IDx as a focused immunology reagent/assay provider, though with a primary antibody-and-kit business model rather than a full multiplexed services offering.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Cell IDx social profiles
Digital presenceCell IDx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cell IDx leadership team
Management profileNumber of profiles
Profiles2 records
Cell IDx funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cell IDx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cell IDx
What does Cell IDx do?
Cell IDx develops and sells multiplexed cellular immunodiagnostic products and related technology for detecting cellular immune markers. The company focuses on enabling simultaneous measurement of multiple immune-cell-related targets to support diagnostic and research workflows. Founded in 2013 and based in San Diego, it serves as a specialized provider in the immunodiagnostics market.
When was Cell IDx founded?
Cell IDx was founded in 2013. It employs 1 to 10 people.
Where is Cell IDx based?
Cell IDx is headquartered in San Diego, United States, in the North America region.
Who are Cell IDx's main competitors?
Direct peers on record are Akoya Biosciences, 10x Genomics, Standard BioTools (formerly Fluidigm), Cytek Biosciences and NanoString Technologies. Broad incumbents are Becton, Dickinson and Company (BD), Beckman Coulter Life Sciences and Thermo Fisher Scientific. Emerging players are BioLegend (part of Revvity/PerkinElmer) and Cell Signaling Technology.
Does Cell IDx have an API?
No public API is recorded for Cell IDx.
What industry is Cell IDx in?
Cell IDx's product category is Clinical Diagnostics. Its primary akta.pro industry code is HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 62151 and its SIC code is 2835.